Table Of Content

Steroids Steroids 65 (2000) 915-917 Author Index Abrahamian, A., 1 Chen, M., 210 Fujisawa, Y., 371 Acosta, C.K., 395 Chen, M., 109 Fuller, P.J., 61 Adamczyk, M., 295, 387 Chen, Y.-Y., 295 Furr, B.J.A., 725 Adamopoulos, D.A., 1 Choi, M.H., 54 Furtmiiller, R., 349 Adlercreutz, H., 339 Chrysanthopoulou, G., 851 Furuta, T., 89, 180 Alfer, J., 763 Chung, B.C., 54 Furuyama, N., 371 Ali, H., 74 Chwalisz, K., 713, 741, 763, 807 Allolio, B., 98 Classen-Linke, I., 763, 773 Al-Mohaisen, M., 8 Clusmann, H., 895 Galagovsky, L.R., 329 Al-—Maharik, N., 339 Coelingh Bennink, H.J.T., 817, 837, 839 Galons, H., 103 Alvarez-Sanchez, F., 687 Colombe, L., 319 Gao, Z., 585 Ancelin, M., 599 Conneely, O.M., 571 Garrido, L., 85 Arlt, W., 98 Conney, A.H., 521 Gebler, J.C., 295 Ayala, M.E., 190 Costantino, G., 483 Ghini, A.A., 349 Ayotte, J., 379 Costantino, V., 138 Ghosh, D., 753 Croxatto, H.B., 681, 703 Giannacodemos, G., | Csérgei, J., 266 Giton, F., 103 Backman, T., 693 Gompel, A., 593 Bahbouh, R., 857 Bahr, M.L., 395 D’ Ambra, T.E., 401 GGrls, H., 305 Bain, D.L., 579 Dancsi, A., 266 Gottlieb, H.E., 46 Balogh, G., 266 Danielsson, K.G., 801 Graham, J.D., 579 Bardin, C.W., 266 de Ziegler, D., 671 Gratsias, Y., 851 Bar-Hava, I., 645 Deckers, G.H., 733 Groen, M.B., 497 Bartley, J., 713 Delansorne, R., 621 Gros, E.G., 329 Basu, S., 157 Dell’ Aversano, C., 138 Grote, J., 387 Baulieu, E.-E., 605 Dessypris, A., 1 Grunberg, S., 831 Bausero, P., 599 Diaz, S., 703 Guiguen, Y., 319 Beier, H.M., 763, 773 Dibbelt, L., 513 Békési, G., 889 Dixon, J.M., 883 Ben-Rafael, Z., 645 Dodd, R.H., 349 Hamid, A., 40 Beusman, I., 593 Dominguez, R., 190 Hamilton, B.P., 379 Beyenburg, S., 895 Donker, T.H., 795 Hamlyn, J.M., 379 Bidlingmaier, F., 98, 895 Dubs, M., 305 Hampl, R., 339 Blankenstein, M.A., 795 Dukat-Abroék, V., 266 Hanssen, R.G.J.M., 733 Bouchard, P., 613 Dukes, M., 725 Hatakeyama, S., 281 Boudi, A., 103 Hattori, K., 117 Boudou, P., 103 Hazra, B.G., 157 Brache, V., 687 Eguchi, N., 180 Heikinheimo, O., 831 Bradlow, H.L., 883 Ei Khissiin, A., 903 Heiman, A.S., 109, 210 Brenner, R.M., 741 Elger, C.E., 895 Henke, R.T., 895 Brodie, A.M.H., 171 Elger, W., 713, 741 Hermsmeyer, K.R., 621 Brown, A.J., 252 Erices, A., 275 Herrler, A., 773 Bukovsky, A., 190 Espey, L.L., 559 Hess-Stumpp, H., 741 Burdett, J.E., 395 Eulry, B., 103 Hewitt, S.C., 551 Burton, G., 349 Hickey, M., 665 Bury, N., 319 Higashi, T., 281 Buteau-Lozano, H., 599 Falkay, G., 266 Hill, M., 857 Bygdeman, M.. 801 Fanchin, R., 671 Hino, A., 24 Fattorusso, E., 138 Hiyamizu, H., 281 Faundes, A., 687 Cai, M.X., 521 Fehér, J., 889 Hodgen, G.D., 733 Callies, F., 98 Fiet, J., 103 Horwitz, K.B., 579 Campbell, M.J., 252 Foekens, J.A., 825 Hsiu, J.G., 733 Caraty, A., 613 Forgez, P., 593 Hiibler, D., 98 Cardounel, A., 8 Forg6, P., 415 Hughes, L.R., 725 Carver, J.M., 637 Fostier, A., 319 Caudle, M.R., 190 Francsics—Czinege, E., 266 Cessac, J.W., 395 Fraser, 1.S., 665 Iguchi, K., 130 Chabbert-Buffet, N., 613 Fu, J.-H., 521 Iturriaga, H., 275 Chakrabarti, P., 157 Fuhrmann, U.U., 741 Iwabuchi, Y., 281 Chaouat, M., 593 Fujimura, K., 24 Iwashima, M., 130 PII: $0039-128X(00)00213-0 916 Author Index / Steroids 65 (2000) 915-917 Jackanicz, T., 687, 703 Majgier-Baranowska, H., 219, 379 Richards, J.S., 559 Jackson, T.A., 579 Mangoni, A., 138 Richer, J.K., 579 Jacobs, J.M., 795 Manjramkar, D.D., 783 Robker, R.L., 559 Jans, C.G.J.M., 497 Marat, K., 219, 379 Rodriguez, H., 409 Jas, G., 143 Marions, L., 801 Rogerson, F.M., 61 Javitt, N.B., 401 Martin, M.S., 206 Rose, U.M., 733 Johansson, E.D.B., 585, 709 Maruo, T., 585 Ross, R.K., 659 Johnson, D.D., 295 Massai, R., 703 Rosténe, W., 593 Joshi, P.L., 157 Matsuo, H., 585 Roth-Isigkeit, A.K., 513 Journé, F., 903 Mattingly, P.G., 295, 387 Rousseau, J., 74 McKenzie, P.P., 190 Rowan, B.G., 545 Meduri, G., 599 Ruan, B., 29 Kakucs, R., 889 Mikola, H., 339 Russell, D.L., 559 Kalimi, M., 8 Miller, W.R., 883 Kalvinsh, I., 143 Mimoun, M., 593 Kamernitzky, A.V., 163 Minakuchi, C., 117, 537 Sachdeva, G., 783 Kapolla, N., 1 Mishell, D.R., Jr., 687 Salva, J., 85 Miura, K., 281 Samoto, T., 585 Kass, L., 409 Molnar, C., 266 San Martin, M., 491 Kasuya, Y., 89, 180 Montes, G.S., 409 Schmucker, P., 513 Katkam, R.R., 783 Moore, J.A., 295 Schneider, B., 713 Kaufmann, G., 713 Morat, P.B., 40 Schénecker, B., 305 Kauss, V., 143 Morrison, P.A., 395 Schoonen, W.G.E.J., 733 Kazem, A., 593 Moutsatsou, P., 851 Schramm, J., 895 Keenan, J.A., 190 Mueck, A.O., 357 Schroepfer, G.J., Jr., 29 Khalid, B.A.K., 40 Muijioz de Toro, M., 409 Schubert, G., 713 Kholkute, $.D., 783 Schulze, S., 124 Kikuchi, R., 281 Schumacher, M., 605 Kim, H.K., 395 Nagasaka, M., 871 Seeger, H., 357 Kim, H.-G., 24 Nakagawa, Y., 117, 537 Sekeris, C.E., 851 Kim, K.R., 54 Nara, K., 130 Sengupta, J., 753 Klijn, J.G.M., 825 Natalini, B., 483 Seo, H.-S., 903 Klinge, C.M., 227, 505 Nicoletti, D., 349 Sepkovic, D.W., 883 Klingmiiller, D., 895 Nicopoulou, S., 1 Setyono-Han, B., 825 Kloosterboer, H.J., 593, 733 Njar, V.C.O., 171 Shalev, J., 645 Ko, D.-H., 210 Numazawa, M., 871 Sharma, S.C., 559 Koeffler, H.P., 252 Nwe, K.H.H., 40 Shelangouski, M., 871 Kogteva, G.S., 163 Shevchenko, V.P., 163 Koide, S.S., 266, 629 Shi, J., 124 Korach, K.S., 551 O'Malley, B.W., 545, 559 Shivesaki, H., 89, 180 Kosh, J.W., 521 Ooi, H., 281 Shimada, K., 281 Kovér, K.E., 415 Ortega, M.J., 85 Shimomura, Y., 585 Krieg, R., 305 Orvieto, R., 645 Sieghart, W., 349 Krusche, C.A., 763, 773 Siekmann, L., 98 Kubodera, N., 281 Sitruk-Ware, R., 651 Kugimiya, S., 117 Pakdel, F., 319 Skinner, D.C., 613 Kulikova, L.E., 163 Pal, D., 157 Smirnov, A.N., 163 Kumar, N., 266, 629 Pan, Y., 387 Soliman, H., 103 Kurachi, O., 585 Pang, J., 29 Somai, S., 593 Paris, J.M., 621 Spencer, T.A., 529 Kuramoto, T., 24 Patil, V., 783 Spitz, I.M., 585, 807, 817, 831, 837, 841 Peleg, S., 252 Sprintz, D., 889 Lacy, J., 401 Pellicciari, R., 483 Srinivasan, P., 401 Lafreniére, J., 74 Perreault, H., 379 Starchenkov, I., 143 Perrot-Applanat, M., 599 Stoffel-Wagner, B., 895 Lahteenmaki, P., 687, 693 Pike, M.C., 659 Stumpf, K., 339 Laios, L., 903 Plate, R., 497 Sundaram, K., 266, 629 Lapcik, O., 339 Pokrovskaya, E.V., 163 Swahn, M.-L., 801 Lardy, H.A., 124 Pore, V.S., 157 Sweet, F., 415 Leclercq, G., 903 Pu, X., 148 Székacs, B., 889 Lee, H.J., 109, 210 Puri, C.P., 783 Szendi, Z., 415 Lee, N.E., 252 Lee, S.-S., 863 Lester, A., 379 Racz, K., 889 Teme Centurién, O.M., 329 Levina, LS., 163 Raju, U., 883 Templeton, J.F., 219, 379 Levitz, M., 883 Ramirez, 3.A., 329 Thalassinos, N., 851 Levy, T., 645 Ramos, J.G., 409 Thalén, A., 16 Li, D., 529 Ranta, S., 831 Thijssen, J.H.H., 795 Lioi, X., 275 Rao, D.S., 252 Touitou, Y., 206, 491 Lippert, T.H., 357 Rao, P.N., 395 Trapencieris, P., 143 Lundeen, S.G., 637 Rath, W., 763 Tsagarakis, S., 851 Luque, E.H., 409 Rauramo, I., 693 Tsong, Y.-Y., 629 Luukkainen, T., 699 Reddy, G.S., 252 Tuba, Z., 266 Lydon, J.P., 559, 571 Reddy, R.E., 295 Tucker, H., 725 Author Index / Steroids 65 (2000) 915-917 917 Tung, L., 579 Wada, H., 24 Xu, S., 521 Tyulmenkov, V.V., 505 Wahala, K., 339 Wang, G.J., 339 Yairi, Y., 645 Wang, K.C., 865 Yan, J.-L., 863 Uehara, M., 339 Wang, Y., 585 Yang, K., 148 Ueno, T., 117, 537 Warchol, T., 401 Yokokawa, A., 180 Une, M., 24 Watzka, M., 895 Yoshii, M., 24 Wickstrém, L.-I., 16 Yoshioka, S., 559 You, Z., 109 Valladares, L., 275 Williams, K.J., 621 Yu, Z., 295 van Duijnhoven, M.W.F., 795 Williams, R.F., 733 van Lier, J.E., 74 Williard, P.G., 252 Van Look, P.F.A., 817 Zakelj-Mavrié, M., 46 Wilson, W.K., 29 Zhang, Z., 637 van Wuijtswinkel, R.C.A.L., 497 Wimalasena, J., 190 Varayoud, J., 409 Zhu, B.T., 521 Varbird, S., 889 Winneker, R.C., 637 Zhu, Y., 637 Verbost, P.M., 733 Wolf, C., 483 Zofkova, I., 857 Verheijen, F.M., 795 Woodburn, J.R., 725 Zorko, M., 46 Villette, J.-M., 103 Wu, J., 295 Zubia, E., 85 Steroids Steroids 65 (2000) 919-922 Subject Index Abortifacient, 157 Bone mineral density, 857 Abortion, 807 Bone remodeling, 857 Acridinium steroid conjugates, 387 Bone resorption, 371 ADAMTS-1, 559 Brassinosteroid, 329 Adrenal androgens, 857 Brassinosteroids, 443 Adrenal insufficiency, 98 Breast, 733 Affinity, 295 Breast cancer, 171, 429, 659, 825 Ag*-HPLC, 29 Breast cancer imaging, 74 Aldosterone, 61 Breast neoplasms, 579 1a@,23(R),25(OH),-24-oxo-19-nor-D,, 252 Breastfeeding women, 703 1a,23(S),25(OH)3-24-oxo-19-nor-D,, 252 1a@,25(OH),-19-nor-D,, 252 1a,25(OH),D,, 252 Calcium, 451 16a-iodoestradiol, 74 Campesterol, 443 17a-hydroxyprogesterone, 103 Cancer, 357 17a-[(4-azido-2-nitrophenyl/5-azido-2-nitro-2,4,6-trifluoropheny])/amino, Carbonyl reductase, 46 459 Cardiac glycoside, 379 17a-[(5-azido-2-nitrobenzoy]l)amidomethyl/ethy!/propy!]-5a-androstane-, Cardiac surgery, 513 459 Cardiopulmonary bypass, 513 Amenorrhea, 693 Cardiovascular surrogate risk markers, 651 Amino alcohol derivatives, 305 Caspase-3, 593 Androgen glucuronide, 54 Cathepsin B, 371 Androgenic activity, 629 Cathepsin K, 371 Androgens, 190, 725 Cathepsin L, 371, 559 Androsterone, 98 cDNA cloning, 319 Angiogenesis, 599 cDNA protein sequence, 148 Animal models, 713 Cell culture, 795 Antedrug, 109, 210 Cellular aging, 190 Antiandrogens, 725 Cervical dilatation, 807 Antibody, 505 Cervical mucus, | Anti-estradiol mAb, 295 Cervix, 409 Antiestrogens, 593, 903 Chemiluminescent probes, 295 Antiglucocorticoid, 157 Chenodeoxycholic acid, 143 Anti-inflammatory steroid, 109 5B-Cholestan-26, 143 Anti-inflammatory steroids, 210 5B-Cholestan-26-oic acids, 143 Antioxidant effect, 889 Cholesterol, 423 Antiprogestin, 157, 733, 753, 801, 831 Cholesterol 7a-hydroxylase, 24 Antiprogestins, 395, 725, 825 Cholic acid, 143 Antiviral, 329 Chromatography, 98 Apoptosis, 593, 795 Circadian, 491 Aromatase, 171 Circadian rhythm, 206 Aromatase inhibitor, 871 '3C-Labeled steroids, 180 Assisted reproduction, 773 Clauberg assay, 266 Assisted reproductive technology, 645 Clavularia viridis, 130 Atherosclerosis, 651 Coactivator, 545 Cochliobolus lunatus, 46 CoMFA, 483 Bcl-2 family proteins, 593 Comparative pharmacology, 713 Bcl-2 protein, 585 Condensation, 401 2B,3B,140,20B-tetrahydroxy-22a-(2-hydroxyacetiloxy)-5B-colest-7, 138 Conformational analysis, 29 11B-HSD1, 148 Conjugated metabolite, 281 11B-hydroxysteroid dehydrogenase, 40 Contraception, 665, 681, 693 17B-Estradiol, 295, 585 Contraceptive, 709 17B-Hydroxysteroid dehydrogenase, 46 Contraceptive implant, 709 BlAcore, 295 Contraceptive ring, 687 Bile acid analogs, 24 Copper complexes, 305 Bile acids, 24, 423 Corticosteroid-binding globulin, 513 Bioactive, 329 Corticosteroids, 16 Biotin, 103 Cortisol, 89, 180, 851 Bisteroid, 219 Cortisol metabolism, 180 Bleeding, 665 Cortisone, 89, 180 Blood vessels, 621 Croton oil-induced ear edema, 210 PII: $0039-128X(00)00214-2 920 Subject Index / Steroids 65 (2000) 919-922 Cultured hepatocytes, 24 GC/MS, 89 5,6-Cyclopropanoandrosta-3,17-diones, 863 Gelatin capsule, 645 5,6-Cyclopropanocholestanes, 863 Gender, 851 Cytotoxicity, 85 Gene, 571 genistein, 339 Glucocorticoid receptor, 8, 851, 895 daidzein, 339 Glucocorticoid resistance, 148 Dehydroepiandrosterone, 491 GnRH pulsatility, 613 Dehydroepiandrosterone (DHEA), 98 Gorgonian, 85 Dehydroepiandrosterone sulfate, 491 Guinea pigs, 148 Deutrium-label, 89 Diacylhydrazines, 117 24,25-Dihydroxyvitamin D,, 281 'H/ '3C NMR, 459 Dimer, 219 Hemodilution, 513 27-Dioic acids, 143 Hippocampus, 895 20-dione acetate, 266 'H-NMR, 16 Diosgenin, 401 18-Homoestradiols, 74 Diurnal rhythm, 851 Hormone replacement therapy, 659, 699 DMBA, 733 HRT, 671, 807 Dysfunctional uterine bleeding, 807 Human, 851 Dysmenorthea, 699 Human breast cyst fluid, 883 Human sex hormone-binding globulin, 459 Hydroperoxidation, 443 Ecdysone, 537 Hydrophobicity, 117, 483 Ecdysone agonists, 537 Hydroxycholesterol, 401 Ecdysteroids, 117, 138 7-Hydroxy steroids, 497 Ectopic pregnancy, 807, 817 Hydroxyestrones, 883 EGF, 585 7a-Hydroxyoxysterols, 529 Embryo, 753, 817 25-Hydroxyvitamin D,, 281 Emergency contraception, 817 Hyodeoxycholic acid, 423 EMSA, 505 Hypothalamus, 613 Endometrial cancer, 659 Endometrial cell culture, 763 Endometrial contraception, 817 Immobilization stress, 8 Endometrial receptivity, 671 Immune adaptation, 190 Endometrial shedding, 817 Immunoassay, 339 Endometriosis, 741, 807 Implant, 681 Endometrium, 599, 665, 713, 733, 741, 753, 773 Implantation, 753 Enzyme properties, 148 Implantation window, 817 Eosinophils, 409 In vitro, 637 3-Epi-24,25-dihydroxyvitamin D, 24-glucuronide, 281 Indan synthon method, 180 Equilibrium constants, 163 Inhibition of LH surge, 817 ERB, 505, 505, 763 Inhibitors, 171 a@ERKO mice, 551 Integrins, 783 Estradiol, 1, 599, 857, 883 Intestinal absorption, 24 Estradiol metabolism, 357 Intrauterine system, 693, 709 Estradiol metabolites, 357 lotrochota birotulata, 138 Estradiol-17B, 371 isoflavones, 339 Estrogen, 409, 551, 593 Isoforms, 571 Estrogen metabolism, 831 Isotopic fractionation, 29 Estrogen receptor, 74, 429, 783, 903 IVF, 807 Estrogen receptors, 579 Estrogens, 903 Estrone, 883 J867, 763 Estrone sulfate, 883 E,-3-Sulfatase activity, 521 6-ester-substituted C19-steroid, 871 Kinetic analysis, 46 6-ether-substituted C19-steroid, 871 Kryptogenin, 401 Etiocholanolone, 98 Etonogestrel, 681 (17a,20E/Z)iodovinylestradiol derivatives, 74 Lactones, 437 Leptogorgia sarmentosa, 85 Leukemia inhibitory factor, 783 Fertility, 733 Levonorgestrel, 681, 687, 693, 699 Flutamide-derivatives, 725 Levonorgestrel-releasing TUS, 585 Frontal lobe, 895 LH, 831 FSH, 831 Lignan, 437 Fungi, 46 Lipids, 651 Liquid chromatography tandem mass spectrometry, 281 Litigation, 709 GABA, 349 Liver, 8, 40 GABA, receptor, 349 Livial, 497 Gamma amino butyric acid, 613 Luteal support, 671 Gas chromatography, 54 LXR, 423 Subject Index / Steroids 65 (2000) 919-922 921 Lymphocytes, 851 Plasma glycoprotein-oligosaccharides, 275 {*H]Ponasterone A, 537 Portal catheterism, 613 Marine steroid, 130 Postpartum contraception, 703 Mass spectrometry, 54, 180 PR, 763 MCF-7 cells, 903 Prednisolone, 109 Meingioma, 795 Pregnancy termination, 801 Melatonin, 206, 491 Primate, 753 Membrane receptor, 451 PRKO mice, 551 Memory, 124 Progestational steroids, 651 Menorthagia, 699 Progesterone, 1, 206, 409, 551, 559, 571, 579, 585, 605, 613, 645, 671, Mesenchymal cells, 190 703, 741, 753 Mesoprogestins, 713, 741 Progesterone 16a,17a-Cycloalkane derivatives, 163 Methoxyfenozide (RH-2485), 117, 537 Progesterone antagonist, 157, 741 6-Methylandrost-4-ene-3,17-diones, 863 Progesterone antagonists, 773, 825, 831 16-methylene-17a-hydroxy-18-methyl-19-norpregn-4-ene-3, 266 Progesterone antagonists (PAs), 807, 817 Mice, 124 Progesterone receptor, 163, 545, 637, 783 Michael reactions, 437 Progesterone receptor modulators, 713, 713, 733, 741, 825, 831 Microbial transformation, 863 Progesterone receptor modulators (PRMs), 807, 817 Mifepristone, 807, 817 Progesterone receptors, 613, 795 Mifepristone analogs, 157 Progestin, 266, 629, 637, 681, 687 Mineralocorticoid receptor, 319, 895 Progestin only contraception, 817 Molecular mechanics calculations, 138 Progestins, 593, 621, 659, 725 Molecular modeling, 871 Progestogens, 665 Molecular oxygen, 443 Prostaglandin analogues, 801 Monkeys, 733 Protein binding, 163 Monoclonal antibodies, 429 mRNA, 148 Mycobacterium sp. (NRRL B-3805), 863 QSAR, 117 Myelination, 605 3D-QSAR, 483 Nestorone, 266, 681, 687, 703 Rainbow trout, 319 Neurosteroid, 605 Rapid effects, 451 Neurosteroids, 349 Rat bile, 281 NMR, 29 Rat prostate cytosolic androgen receptor, 459 2D NOESY, 16 Rat uterus, 163 Nomegestrol acetate, 621 Rats, 733 Noncirrhotic alcoholic, 275 Receptor, 61, 551, 559, 571 19-Norprogesterones, 651 Reduction, 219 19-Norsteroids, 157 Reductive elimination, 401 Nuclear receptors, 423 Regulation, 795 Rofleponide 6-hydroxy!lation, 16 Rofleponide 6-oxogenation, 16 O-(Acridinium)hydroxylamine, 387 RU-486, 409 Onapristone, 783 Ontogeny, 190 Oral contraceptive, 709 Schiff bases, 305 ORG OD14, 497 Schwann cells, 605 Ouabain, 379 Sciatic nerve, 605 Ovarian steroidogenic cells, 190 Selectivity, 629 Ovarian stimulation, 773 Sensitivity, 851 Ovulation, 551, 559, 687, 693, 713 Sex differences, 895 Ovulation inhibition, 817 Sex hormone binding globulin, 1, 857 6-Oxapregnanolone, 349 Sf-9 cell line, 537 6-Oxasteroids, 349 SHBG, 275, 831 Oxidation, 379 Signal transduction, 451 7-Oxo-dehydroepiandrosterone, 124 Silica gel, 443 Oxysteroids, 401 Silver-ion MPLC, 29 Oxysterols, 423, 529 Sodium channel, 61 Sodium transport, 61 Soft coral, 130 p53, 593 Spiro enone, 109 Parturition, 409 SRC-1, 545 PCN, 521 Stainless steel capillary column, 54 PGF,,, secretion, 713 Steroid, 295, 349, 357, 371, 379, 545, 559, 571, 637, 795, 883 Pharmaceutical market, 709 Steroid binding, 319 Pharmacokinetics, 645 Steroid hormone, 451 Pharmacology, 629 Steroid hormones, 889 Photoaffinity labeling reagents, 459 Steroid receptor, 505 phytoestrogens, 339 Steroid receptors, 579 Phytohormone, 329 Steroids, 305, 395, 415, 483, 491, 621, 665, 773, 801 Pineal, 206 Structural elucidation, 130 Pineal gland, 491 Structure-activity relationship, 87! 999? Subject Index / Steroids 65 (2000) 919-922 Superoxide anion, 889 Unbound cortisol, 513 Swe oxidation, 29 Unsaturated sterols, 29 Synthesis, 16, 266, 329, 395, 437, 443, 529 Urinary steroid excretion, 98 Uterine myoma, 585 Uterine myoma, 807 Tamoxifen, 409, 579 Tebufenozide (RH-5992), 117, 537 Uterine receptivity, 783 Temporal lobe, 895 Testis, 40 Testosterone, 1, 857 Vaginal, 671 Tetrahydrometabolites, 89 Vaginal ring, 703 Tetrahydropyranyl ethers, 415 Vaginal tablet, 645 Tibolone, 497 Vascular endothelial growth factor (VEGF) receptors, 599 Time-dependent inactivation, 871 Vasomotion, 651 Time-resolved fluorescence, 339 VEGF, 763 Time-resolved fluoroimmunoassay, 103 Vessels, 665 TNF-a, 851 Vitamin D, 451 Total cortisol, 513 Tracers, 387 Transcription, 545 Transcriptional coregulators, 579 X-ray analysis, 305 Transforming growth factor B, 783 Transforming growth factor B receptor, 783 Trialkylsilylation, 379 Yonarasterol, 130 Trimegestone, 637 Trimethylsilylation, 54, 219 Tumors, 733 Zinc, 219 Two-dimensional NMR spectroscopy, 415 ZK 137316, 763